GMED Globus Medical Inc

Price (delayed)

$71.20

Market cap

$7.15B

P/E Ratio

57.89

Dividend/share

N/A

EPS

$1.23

Enterprise value

$6.96B

Sector: Healthcare
Industry: Medical Devices

Highlights

GMED's equity is up by 15% year-on-year and by 3.8% since the previous quarter
The gross profit has grown by 5% from the previous quarter
The company's net income rose by 19% QoQ but it fell by 18% YoY
The EPS has grown by 18% since the previous quarter but it has declined by 18% year-on-year
The P/E is 65% more than the 5-year quarterly average of 35.0 and 6% more than the last 4 quarters average of 54.4
GMED's gross margin is down by 4.6% year-on-year

Key stats

What are the main financial stats of GMED
Market
Shares outstanding
100.36M
Market cap
$7.15B
Enterprise value
$6.96B
Valuations
Price to earnings (P/E)
57.89
Price to book (P/B)
4.55
Price to sales (P/S)
8.61
EV/EBIT
50.35
EV/EBITDA
34.17
EV/Sales
8.43
Earnings
Revenue
$825.81M
EBIT
$138.26M
EBITDA
$203.72M
Free cash flow
$165.05M
Per share
EPS
$1.23
Free cash flow per share
$1.65
Book value per share
$15.66
Revenue per share
$8.27
TBVPS
$15.04
Balance sheet
Total assets
$1.74B
Total liabilities
$174.9M
Debt
$0
Equity
$1.56B
Working capital
$690.7M
Liquidity
Debt to equity
0
Current ratio
6.58
Quick ratio
4.56
Net debt/EBITDA
-0.91
Margins
EBITDA margin
24.7%
Gross margin
72.9%
Net margin
14.7%
Operating margin
16.7%
Efficiency
Return on assets
7.6%
Return on equity
8.4%
Return on invested capital
13.1%
Return on capital employed
8.6%
Return on sales
16.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GMED stock price

How has the Globus Medical stock price performed over time
Intraday
0.21%
1 week
2.24%
1 month
6.27%
1 year
47.26%
YTD
9.17%
QTD
15.45%

Financial performance

How have Globus Medical's revenue and profit performed over time
Revenue
$825.81M
Gross profit
$602.18M
Operating income
$137.53M
Net income
$121.67M
Gross margin
72.9%
Net margin
14.7%
The operating income has increased by 23% QoQ but it has decreased by 16% YoY
The net margin has declined by 21% year-on-year but it has increased by 13% since the previous quarter
The company's operating margin fell by 19% YoY but it rose by 18% QoQ
The company's net income rose by 19% QoQ but it fell by 18% YoY

Growth

What is Globus Medical's growth rate over time

Valuation

What is Globus Medical stock price valuation
P/E
57.89
P/B
4.55
P/S
8.61
EV/EBIT
50.35
EV/EBITDA
34.17
EV/Sales
8.43
The P/E is 65% more than the 5-year quarterly average of 35.0 and 6% more than the last 4 quarters average of 54.4
The EPS has grown by 18% since the previous quarter but it has declined by 18% year-on-year
The stock's P/B is 23% more than its 5-year quarterly average of 3.7 and 20% more than its last 4 quarters average of 3.8
GMED's equity is up by 15% year-on-year and by 3.8% since the previous quarter
GMED's P/S is 41% higher than its 5-year quarterly average of 6.1 and 23% higher than its last 4 quarters average of 7.0
Globus Medical's revenue has increased by 4.7% QoQ and by 4.1% YoY

Efficiency

How efficient is Globus Medical business performance
The ROA is down by 25% year-on-year but it is up by 15% since the previous quarter
Globus Medical's return on equity has decreased by 24% YoY but it has increased by 15% QoQ
GMED's ROIC is down by 21% year-on-year but it is up by 18% since the previous quarter
The return on sales has declined by 19% year-on-year but it has grown by 18% since the previous quarter

Dividends

What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GMED.

Financial health

How did Globus Medical financials performed over time
The company's total liabilities has surged by 51% YoY
GMED's total assets is up by 17% year-on-year and by 3.5% since the previous quarter
The debt is 100% smaller than the equity
GMED's equity is up by 15% year-on-year and by 3.8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.